Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Poseida Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Poseida Therapeutics

Poseida Therapeutics

Public

San Diego-based Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company innovating cell and gene therapeutics.

HQ
San Diego, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded in San Diego, Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing next-generation cell and gene therapeutics. The company's core mission is to redefine treatment paradigms for life-threatening cancers and genetic diseases through innovative genetic engineering technologies. Poseida's proprietary platform focuses on creating advanced therapies that offer new hope to patients facing severe medical conditions.

Poseida Therapeutics has garnered attention from notable investors and industry leaders, contributing to its rapid growth and development. The company has achieved significant milestones in clinical trials, demonstrating the potential of its cutting-edge therapies. Poseida's impact is marked by its commitment to pioneering treatments that could transform the landscape of cancer and genetic disease management, positioning it as a leader in the biopharmaceutical industry.

Poseida Therapeutics - Similar Companies

Voyager Therapeutics logo

Voyager Therapeutics

Poseidon Innovation logo

Poseidon Innovation

Kriya Therapeutics logo

Kriya Therapeutics

Denali Therapeutics logo

Denali Therapeutics

Sorrento Therapeutics logo

Sorrento Therapeutics

Legend Biotech logo

Legend Biotech

legendbiotech.com

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

Excision BioTherapeutics logo

Excision BioTherapeutics

Theragene Pharmaceuticals logo

Theragene Pharmaceuticals

Pliant Therapeutics logo

Pliant Therapeutics

pliantrx.com

Sangamo Therapeutics logo

Sangamo Therapeutics

sangamo.com

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

Locanabio logo

Locanabio

Spotlight Therapeutics logo

Spotlight Therapeutics

spotlighttx.com

Regenxbio logo

Regenxbio

regenxbio.com

Poseida Therapeutics - Quick Facts

Who are Poseida Therapeutics' competitors?

Companies similar to Poseida Therapeutics include Voyager Therapeutics, Poseidon Innovation, Kriya Therapeutics and Denali Therapeutics.

When was Poseida Therapeutics founded?

Poseida Therapeutics was founded in 2014.

Where is Poseida Therapeutics' headquarters located?

Poseida Therapeutics' headquarters is located in San Diego, CA, US.

When was Poseida Therapeutics' last funding round?

Poseida Therapeutics' most recent funding round was for $50M (USD) in August 2023.

How much has Poseida Therapeutics raised to-date?

As of Aug 7, 2023, Poseida Therapeutics has raised a total of $460.5M (USD).

How many employees does Poseida Therapeutics have?

Poseida Therapeutics has 314 employees as of Feb 6, 2024.

Poseida Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Gene Therapies
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research